The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Anatomy of Mdm2 and Mdm4 in evolution
Abstract
Mouse double minute (Mdm) genes span an evolutionary timeframe from the ancient eukaryotic placozoa Trichoplax adhaerens to Homo sapiens, implying a significant and possibly conserved cellular role throughout history. Maintenance of DNA integrity and response to DNA damage involve many key regulatory pathways, including precise control over the tumour suppressor protein p53. In most vertebrates, degradation of p53 through proteasomal targeting is primarily mediated by heterodimers of Mdm2 and the Mdm2-related protein Mdm4 (also known as MdmX). Both Mdm2 and Mdm4 have p53-binding regions, acidic domains, zinc fingers, and C-terminal RING domains that are conserved throughout evolution. Vertebrates typically have both Mdm2 and Mdm4 genes, while analyses of sequenced genomes of invertebrate species have identified single Mdm genes, suggesting that a duplication event occurred prior to emergence of jawless vertebrates about 550-440 million years ago. The functional relationship between Mdm and p53 in T. adhaerens, an organism that has existed for 1 billion years, implies that these two proteins have evolved together to maintain a conserved and regulated function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Single MDM-family genes were identified in many, but not all, invertebrates, including placozoans, sea anemones, mollusks, and tunicates [1, 42, 65].”
From Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog (2022) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“Gene-specific morpholino oligonucleotides (MO) are commonly injected into zebrafish embryos to transiently suppress gene expression (Nasevicius and Ekker, 2000).”
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
Ding, K., Lu, Y., Nikolovska-Coleska, Z., Wang, G., Qiu, S., Shangary, S., Gao, W., Qin, D., Stuckey, J., Krajewski, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051122a · Cited by 702 · cited 1×
“These include stapled peptides (Brown et al., 2013; Chang et al., 2013), cyclotides (Ji et al., 2013), and small molecule inhibitors (Vassilev et al., 2004; Ding et al., 2006; Koblish et al., 2006; Shangary et al., 2008; Lakoma et al., 2015).”
Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., Nikolovska-Coleska, Z., Ding, K., Wang, G., Chen, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708917105 · Cited by 660 · cited 2×
“The paralogue Mdm4 (also called MdmX) was identified in a cDNA screen for p53 binding partners and was named for its homology with Mdm2 (Shvarts et al., 1996).”
MDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · cited 2×
“The paralogue Mdm4 (also called MdmX) was identified in a cDNA screen for p53 binding partners and was named for its homology with Mdm2 (Shvarts et al., 1996).”
Inactivation of the p53 pathway in retinoblastoma
Laurie, N. A., Donovan, S. L., Shih, C.-S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006) · Nature · doi:10.1038/nature05194 · Cited by 595
Parant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517
p300/MDM2 complexes participate in MDM2-mediated p53 degradation
Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80140-9 · Cited by 414 · cited 1×
“Together, the acidic and zinc finger domains form binding sites for a number of regulatory proteins, including p300 (Grossman et al., 1998; Sabbatini and McCormick, 2002), YY1 (Grönroos et al., 2004; Sui et al., 2004), ARF (Kamijo et al., 1998; Jackson et al., 2001), and PML (Bernardi et al.,…”
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
Pazgier, M., Liu, M., Zou, G., Yuan, W., Li, C., Li, C., Li, J., Monbo, J., Zella, D., Tarasov, S. G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900947106 · Cited by 391 · cited 1×
“Mdm4 is also ubiquitinated by Mdm2, and this degradation of Mdm4 allows for p53 activity in response to cytotoxic stress (Pereg et al., 2005; Jin et al., 2006).”
Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation
Stommel, J. M., & Wahl, G. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600145 · Cited by 386 · cited 1×
“In nonstressed cells, this feedback loop maintains a low level of Mdm2 and p53: the half-lives of the two proteins in unstressed cells are 20 min (Stommel and Wahl, 2004).”
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
Linares, L. K., Hengstermann, A., Ciechanover, A., Müller, S., & Scheffner, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2030930100 · Cited by 361
MDM4 is a key therapeutic target in cutaneous melanoma
Gembarska, A., Luciani, F., Fedele, C., Russell, E. A., Dewaele, M., Villar, S., Zwolinska, A., Haupt, S., de Lange, J., Yip, D., et al. (2012) · Nature Medicine · doi:10.1038/nm.2863 · Cited by 327 · cited 1×
“Human Mdm4 overexpression is implicated in a number of tumours, such as leukaemias, retinoblastomas, testicular cancers, and melanomas (Laurie et al., 2006; Han et al., 2007; Koster et al., 2011; Gembarska et al., 2012).”
Rayburn, E., Zhang, R., He, J., & Wang, H. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053332636 · Cited by 265
MDM2 and MDM4: p53 regulators as targets in anticancer therapy
Toledo, F., & Wahl, G. M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.022 · Cited by 261
Origin and evolution of the ribosome
Fox, G. E. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003483 · Cited by 258
Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage
Pereg, Y., Shkedy, D., de Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Teunisse, A. F. A. S., Lehmann, W. D., Jochemsen, A. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408595102 · Cited by 181
The role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168
The sea lamprey meiotic map improves resolution of ancient vertebrate genome duplications
Smith, J. J., & Keinath, M. C. (2015) · Genome Research · doi:10.1101/gr.184135.114 · Cited by 152
MDMX regulation of p53 response to ribosomal stress
Gilkes, D. M., Chen, L., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601424 · Cited by 142 · cited 1×
“Whilst RPL11 interacts with Mdm2 and placozoan Mdm, it does not bind to Mdm4 (Gilkes et al., 2006).”
Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53
Kostic, M., Matt, T., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.08.027 · Cited by 128 · cited 1×
“Unlike the typical C3HC4 or C4C4 zinc coordination, the cross- brace motifs in Mdm2 and Mdm4 have a unique C2H2C4 structure, as depicted in Figure 1A (Kostic et al., 2006; Linke et al., 2008).”
A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
Post, S. M., Quintás-Cardama, A., Pant, V., Iwakuma, T., Hamir, A., Jackson, J. G., Maccio, D. R., Bond, G. L., Johnson, D. G., Levine, A. J., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.07.010 · Cited by 127
Haploinsufficiency of Mdm2 and Mdm4 in Tumorigenesis and Development
Terzian, T., Wang, Y., Van Pelt, C. S., Box, N. F., Travis, E. L., & Lozano, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00555-06 · Cited by 116
MDM2 and MDMX can interact differently with ARF and members of the p53 family
Wang, X., Arooz, T., Siu, W. Y., Chiu, C. H. S., Lau, A., Yamashita, K., & Poon, R. Y. C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02124-x · Cited by 94
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase
Okamoto, K., Taya, Y., & Nakagama, H. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.021 · Cited by 76
MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation
Jackson, M. W., Lindström, M. S., & Berberich, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010685200 · Cited by 74
Mdmx promotes genomic instability independent of p53 and Mdm2
Carrillo, A. M., Bouska, A., Arrate, M. P., & Eischen, C. M. (2015) · Oncogene · doi:10.1038/onc.2014.27 · Cited by 69 · cited 2×
“Furthermore, Mdm2 and Mdm4 have been reported to have p53-independent roles (Melo and Eischen, 2012; Li and Lozano, 2013; Carrillo et al., 2015).”
MDMX inhibits the p300/CBP-mediated acetylation of p53
Sabbatini, P., & McCormick, F. (2002) · DNA and Cell Biology · doi:10.1089/104454902320219077 · Cited by 62
Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression
Lushnikova, T., Bouska, A., Odvody, J., Dupont, W. D., & Eischen, C. M. (2011) · Oncogene · doi:10.1038/onc.2011.172 · Cited by 40
Protecting the genome from mdm2 and mdmx
Melo, A. N., & Eischen, C. M. (2012) · Genes & Cancer · doi:10.1177/1947601912454139 · Cited by 20
Research works printed but not linked: 92
- Bennett-Lovsey, 2002, The SWIB and the MDM2 domains are homologous and share a common fold, Bioinformatics, 18, 626, 10.1093/bioinformatics/18.4.626 · DOI
- Bernardi, 2004, PML regulates p53 stability by sequestering Mdm2 to the nucleolus, Nat. Cell Biol., 6, 665, 10.1038/ncb1147 · DOI · Paper page
- Bista, 2013, MDMX contains an autoinhibitory sequence element, Proc. Natl Acad. Sci. USA, 110, 17814, 10.1073/pnas.1317398110 · DOI
- Blackford, 2009, Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation, J. Virol., 83, 4000, 10.1128/JVI.02417-08 · DOI
- Brown, 2013, Stapled peptides with improved potency and specificity that activate p53, ACS Chem. Biol., 8, 506, 10.1021/cb3005148 · DOI · Paper page
- Bursać, 2012, Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress, Proc. Natl Acad. Sci. USA, 109, 20467, 10.1073/pnas.1218535109 · DOI · Paper page
- Cahilly-Snyder, 1987, Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line, Somat. Cell Mol. Genet., 13, 235, 10.1007/BF01535205 · DOI · Paper page
- Chakraborty, 2015, Corp regulates p53 in Drosophila melanogaster via a negative feedback loop, PLoS Genet., 11, e1005400, 10.1371/journal.pgen.1005400 · DOI
- Chang, 2013, Stapled α-helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy, Proc. Natl Acad. Sci. USA, 110, E3445, 10.1073/pnas.1303002110 · DOI · Paper page
- Chao, 2015, Mechanisms of p53 degradation, Clin. Chim. Acta, 438, 139, 10.1016/j.cca.2014.08.015 · DOI
- Chemes, 2015, Convergent evolution and mimicry of protein linear motifs in host-pathogen interactions, Curr. Opin. Struct. Biol., 32, 91, 10.1016/j.sbi.2015.03.004 · DOI
- Chène, 2004, Inhibition of the p53-MDM2 interaction: targeting a protein-protein interface, Mol. Cancer Res., 2, 20, 10.1158/1541-7786.20.2.1 · DOI
- Cheng, 2011, The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity, J. Virol., 85, 765, 10.1128/JVI.01890-10 · DOI
- Chua, 2015, Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish, Oncogene, 34, 5933, 10.1038/onc.2015.57 · DOI
- Coffill, 2016, The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans, Genes Dev., 30, 281, 10.1101/gad.274118.115 · DOI · Paper page
- Dolezelova, 2012, Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability, FEBS Lett., 586, 2225, 10.1016/j.febslet.2012.05.034 · DOI
- Donati, 2013, 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint, Cell Rep., 4, 87, 10.1016/j.celrep.2013.05.045 · DOI · Paper page
- Fakharzadeh, 1991, Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line, EMBO J., 10, 1565, 10.1002/j.1460-2075.1991.tb07676.x · DOI · Paper page
- Fei, 2003, P53 and radiation responses, Oncogene, 22, 5774, 10.1038/sj.onc.1206677 · DOI · Paper page
- Galli, 2010, MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation, J. Cell Sci., 123, 2423, 10.1242/jcs.061010 · DOI
- Grand, 1999, Definition of a major p53 binding site on Ad2E1B58K protein and a possible nuclear localization signal on the Ad12E1B54K protein, Oncogene, 18, 955, 10.1038/sj.onc.1202358 · doi:10.1038/sj.onc.1202358
- Grönroos, 2004, YY1 inhibits the activation of the p53 tumor suppressor in response to gienotoxic stress, Proc. Natl Acad. Sci. USA, 101, 12165, 10.1073/pnas.0402283101 · DOI · Paper page
- Gu, 2002, Mutual dependence of MDM2 and MDMX in their functional inactivation of p53, J. Biol. Chem., 277, 19251, 10.1074/jbc.C200150200 · DOI · Paper page
- Guo, 2013, Ionizing radiation induces a dramatic persistence of p53 protein accumulation and DNA damage signaling in mutant p53 zebrafish, Oncogene, 32, 4009, 10.1038/onc.2012.409 · DOI
- Gustin, 2011, Viral takeover of the host ubiquitin system, Front. Microbiol., 2, 161, 10.3389/fmicb.2011.00161 · DOI
- Han, 2007, HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target, Mod. Pathol., 20, 54, 10.1038/modpathol.3800727 · DOI
- Harada, 2002, Analysis of the adenovirus E1B-55 K-anchored proteome reveals its link to ubiquitination machinery, J. Virol., 76, 9194, 10.1128/JVI.76.18.9194-9206.2002 · DOI · Paper page
- Haupt, 1997, Mdm2 promotes the rapid degradation of p53, Nature, 387, 296, 10.1038/387296a0 · DOI · Paper page
- He, 2016, Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop, Oncotarget, 7, 16217, 10.18632/oncotarget.7479 · DOI
- Horn, 2008, Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway, Oncogene, 27, 5774, 10.1038/onc.2008.189 · DOI
- Iyappan, 2010, Turning the RING domain protein MdmX into an active ubiquitin-protein ligase, J. Biol. Chem., 285, 33065, 10.1074/jbc.M110.115113 · DOI · Paper page
- Ji, 2013, In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide, J. Am. Chem. Soc., 135, 11623, 10.1021/ja405108p · DOI · Paper page
- Jin, 2006, 14-3-3γ binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation, EMBO J., 25, 1207, 10.1038/sj.emboj.7601010 · DOI
- Jones, 1998, Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis, Proc. Natl Acad. Sci. USA, 95, 15608, 10.1073/pnas.95.26.15608 · DOI · Paper page
- Kao, 1990, Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55 K proteins, Virology, 179, 806, 10.1016/0042-6822(90)90148-K · DOI · Paper page
- Koblish, 2006, Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo, Mol. Cancer Ther., 5, 160, 10.1158/1535-7163.MCT-05-0199 · DOI · Paper page
- Koster, 2011, Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway, Cell Death Dis., 2, e148, 10.1038/cddis.2011.33 · DOI
- Kress, 1979, Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum, J. Virol., 31, 472, 10.1128/jvi.31.2.472-483.1979 · DOI · Paper page
- Kubbutat, 1997, Regulation of p53 stability by Mdm2, Nature, 387, 299, 10.1038/387299a0 · DOI · Paper page
- Lakoma, 2015, The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma, Cell Death Discov., 1, 15026, 10.1038/cddiscovery.2015.26 · DOI
- Lane, 2010, The Mdm2 and p53 genes are conserved in the Arachnids, Cell Cycle, 9, 748, 10.4161/cc.9.4.10616 · DOI
- Lane, 2010, Mdm2 and p53 are highly conserved from placozoans to man, Cell Cycle, 9, 540, 10.4161/cc.9.3.10516 · DOI
- Lane, 1979, T antigen is bound to a host protein in SV40-transformed cells, Nature, 278, 261, 10.1038/278261a0 · DOI · Paper page
- Lane, 2012, Mdm2 in evolution, Genes Cancer, 3, 320, 10.1177/1947601912458285 · DOI
- Leonova, 2013, p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs, Proc. Natl Acad. Sci. USA, 110, E89, 10.1073/pnas.1216922110 · DOI · Paper page
- Leslie, 2015, The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization, J. Biol. Chem., 290, 12941, 10.1074/jbc.M115.644435 · DOI
- Levine, 2016, P53 and the defenses against genome instability caused by transposons and repetitive elements, Bioessays, 38, 508, 10.1002/bies.201600031 · DOI
- Li, 2013, Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy, Clin. Cancer Res., 19, 34, 10.1158/1078-0432.CCR-12-0053 · DOI · Paper page
- Li, 2016, MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome, Sci. Transl. Med., 8, 336ra61, 10.1126/scitranslmed.aad9370 · DOI
- Lin, 1994, Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein, Genes Dev., 8, 1235, 10.1101/gad.8.10.1235 · DOI · Paper page
- Linke, 2008, Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans, Cell Death Differ., 15, 841, 10.1038/sj.cdd.4402309 · DOI · Paper page
- Linzer, 1979, Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells, Cell, 17, 43, 10.1016/0092-8674(79)90293-9 · DOI · Paper page
- Liu, 2011, p53, oxidative stress, and aging, Antioxid. Redox Signal., 15, 1669, 10.1089/ars.2010.3644 · DOI · Paper page
- Liu, 2016, Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis, Oncogene
- Lunardi, 2010, A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network, Proc. Natl Acad. Sci. USA, 107, 6322, 10.1073/pnas.1002447107 · DOI
- Macias, 2010, An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 interaction, Cancer Cell, 18, 231, 10.1016/j.ccr.2010.08.007 · DOI · Paper page
- Mehta, 2013, Evidence for at least six Hox clusters in the Japanese lamprey (Lethenteron japonicum), Proc. Natl Acad. Sci. USA, 110, 16044, 10.1073/pnas.1315760110 · DOI · Paper page
- Miciak, 2016, Long story short: p53 mediates innate immunity, Biochim. Biophys. Acta, 1865, 220
- Migliorini, 2002, Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation, J. Biol. Chem., 277, 7318, 10.1074/jbc.M108795200 · DOI
- Moll, 2004, p63 and p73: roles in development and tumor formation, Mol. Cancer Res., 2, 371, 10.1158/1541-7786.371.2.7 · DOI · Paper page
- Momand, 1998, The MDM2 gene amplification database, Nucleic Acids Res., 26, 3453, 10.1093/nar/26.15.3453 · DOI · Paper page
- Momand, 2011, The evolution of MDM2 family genes, Gene, 486, 23, 10.1016/j.gene.2011.06.030 · DOI · Paper page
- Momand, 1992, The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell, 69, 1237, 10.1016/0092-8674(92)90644-R · DOI · Paper page
- Nasevicius, 2000, Effective targeted gene ‘knockdown’ in zebrafish, Nat. Genet., 26, 216, 10.1038/79951 · DOI · Paper page
- Nicolas, 2016, Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress, Nat. Commun., 7, 11390, 10.1038/ncomms11390 · DOI · Paper page
- Nomoto, 1997, Gene structure of rat BAF60b, a component of mammalian SW1/SNF complexes, and its physical linkage to the growth hormone gene and transcription factor SUG/proteasome p45 gene, Gene, 202, 157, 10.1016/S0378-1119(97)00469-1 · DOI
- Pant, 2016, Distinct downstream targets manifest p53-dependent pathologies in mice, Oncogene, 35, 5713, 10.1038/onc.2016.111 · DOI
- Querido, 2001, Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex, Genes Dev, 15, 3104, 10.1101/gad.926401 · DOI · Paper page
- Ramakrishnan, 2014, The ribosome emerges from a black box, Cell, 159, 979, 10.1016/j.cell.2014.10.052 · DOI
- Ranaweera, 2013, Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity, J. Biol. Chem., 288, 18939, 10.1074/jbc.M113.454470 · DOI
- Sasaki, 2011, Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11, Nat. Med., 17, 944, 10.1038/nm.2392 · DOI · Paper page
- Saville, 2004, Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo, J. Biol. Chem., 279, 42169, 10.1074/jbc.M403362200 · DOI · Paper page
- Sermeus, 2011, Reciprocal influence of the p53 and the hypoxic pathways, Cell Death Dis., 2, e164, 10.1038/cddis.2011.48 · DOI · Paper page
- Siau, 2016, Functional characterization of p53 pathway components in the ancient metazoan Trichoplax adhaerens, Sci. Rep., 6, 33972, 10.1038/srep33972 · DOI · Paper page
- Sloan, 2013, The 5 S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress, Cell Rep., 5, 237, 10.1016/j.celrep.2013.08.049 · DOI · Paper page
- Snyder, 1988, A gene amplified in a transformed mouse cell line undergoes complex transcriptional processing and encodes a nuclear protein, J. Biol. Chem., 263, 17150, 10.1016/S0021-9258(18)37511-2 · DOI
- de Souza, 2010, Diversity and evolution of chromatin proteins encoded by DNA viruses, Biochim. Biophys. Acta, 1799, 302, 10.1016/j.bbagrm.2009.10.006 · DOI
- Sui, 2004, Yin Yang 1 is a negative regulator of p53, Cell, 117, 859, 10.1016/j.cell.2004.06.004 · DOI · Paper page
- Tan, 2015, Assessing the efficacy of Mdm2/Mdm4-inhibiting stapled peptides using cellular thermal shift assays, Sci. Rep., 5, 12116, 10.1038/srep12116 · DOI
- Tashakori, 2016, p53 activity dominates that of p73 upon Mdm4 loss in development and tumorigenesis, Mol. Cancer Res., 14, 56, 10.1158/1541-7786.MCR-15-0346 · DOI
- Thisse, 2000, The Mdm2 gene of zebrafish (Danio rerio): preferential expression during development of neural and muscular tissues, and absence of tumor formation after overexpression of its cDNA during early embryogenesis, Differentiation, 66, 61, 10.1046/j.1432-0436.2000.660201.x · DOI
- Van de Mark, 2015, MDM1 is a microtubule-binding protein that negatively regulates centriole duplication, Mol. Biol. Cell, 26, 3788, 10.1091/mbc.E15-04-0235 · DOI
- Vassilev, 2004, In vivo activation of the p53 pathway by small-molecule antagonists of MDM2, Science, 303, 844, 10.1126/science.1092472 · DOI · Paper page
- Wang, 1996, Diversity and specialization of mammalian SWI/SNF complexes, Genes Dev., 10, 2117, 10.1101/gad.10.17.2117 · DOI · Paper page
- Wimmer, 2016, PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53, Oncogene, 35, 69, 10.1038/onc.2015.63 · DOI
- Winston, 1992, Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection, Trends Genet., 8, 387, 10.1016/0168-9525(92)90300-S · DOI · Paper page
- Wu, 2015, MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function, Oncotarget, 6, 21479, 10.18632/oncotarget.4086 · DOI
- Wylie, 2016, p53 genes function to restrain mobile elements, Genes Dev., 30, 64, 10.1101/gad.266098.115 · DOI · Paper page
- Zdzalik, 2010, Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73, Cell Cycle, 9, 4584, 10.4161/cc.9.22.13871 · DOI
- Zheng, 2015, Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation, Genes Dev., 29, 1524, 10.1101/gad.261792.115 · DOI
- Zhou, 2015, Ribosomal proteins: functions beyond the ribosome, J. Mol. Cell Biol., 7, 92, 10.1093/jmcb/mjv014 · DOI · Paper page
- Zilfou, 2009, Tumor suppressive functions of p53, Cold Spring Harb. Perspect. Biol., 1, a001883, 10.1101/cshperspect.a001883 · DOI · Paper page
Cited by
Tisato, V., Voltan, R., Gonelli, A., Secchiero, P., & Zauli, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0500-5 · Cited by 256
Zhang, Q., Balourdas, D.-I., Baron, B., Senitzki, A., Haran, T. E., Wiman, K. G., Soussi, T., & Joerger, A. C. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04653-8 · Cited by 14
Mihalič, F., Åberg, E., Farkhondehkish, P., Theys, N., Andersson, E., & Jemth, P. (2023) · Protein Science · doi:10.1002/pro.4684 · Cited by 6
Metadata
- Authors
- Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R.
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-01
- Volume
- 9
- Issue
- 1
- Pages
- 3-15
- ISSN
- 1759-4685
- Cited by
- 35
- References
- 34
- Language
- en
- Funders
- Agency for Science, Technology and Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.